Anticorps Monoclonal anti-NeutraKine® IFN Alpha 2A

NeutraKine® IFN Alpha 2A Monoclonal Antibody for Neutralization, ELISA

Hôte / Isotype

Mouse / IgG1

Réactivité testée

Humain

Applications

Neutralization, ELISA

Conjugaison

Non conjugué

CloneNo.

2H8G1

N° de cat : 69008-1-Ig

Synonymes

IFN alpha 2, IFNA, IFNA2, IFN-alpha 2, INFA2, Interferon alpha 2, Interferon alpha A, interferon, alpha 2, LeIF A, NeutraKine® IFN Alpha 2A



Neutralization

Informations sur le produit

69008-1-Ig cible NeutraKine® IFN Alpha 2A dans les applications de Neutralization, ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Mouse / IgG1
Clonalité Monoclonal
Type Anticorps
Immunogène human Humankine IFN Alpha 2A protein HZ-1066
Nom complet interferon, alpha 2
Symbole du gène IFNA2
Identification du gène (NCBI) 3440
Conjugaison Non conjugué
Forme Lyophilized Powder
Méthode de purification Purification par protéine G
Tampon de stockage PBS stérile.
Endotoxin<0.1 EU/μg
ReconstitutionThis product was lyophilized from a 0.2 μm filtered solution in PBS. Reconstitute at 1.0 mg/mL in sterile H2O before use.
Stability and StorageLyophilized antibodies are stable for 1 year from the date of receipt if stored between (-20°C) and (-80°C). Upon reconstitution we recommend that the solution can be stored at (4°C) for short term or at (-20°C) to (-80°C) for long term. Repeated freeze thaw cycles should be avoided with reconstituted products.

Informations générales

Interferon alpha 2 is a type 1 interferon. Interferon alpha 2 is secreted by virus-infected cells and inhibits other cells from further infection. Recombinant human interferon alpha 2 has been approved for therapeutic application in a range of human oncological and viral diseases. Three Interferon alpha 2 subvariants (2A, 2B, 2C) differ by only one or two amino acids at positions 23 and/or 34 of the mature protein (PMID: 25982860; 10672347; 1694761).

This antibody can be used to neutralize the bioactivity of Interferon alpha 2.